Adam Wiggins

Adam Wiggins is a hacker and entrepreneur. As a co-founder of Heroku he spends his days thinking about the future of application development. Follow him online at @hirodusk and http://adam.heroku.com or get in touch here.

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey
San Francisco is the center of the tech world. But after three months in Europe, my conclusion is that there’s a major new contender as a great place to start startups:... Read more »
Programming Literacy Done Right: It’s About the Tools
Bonnie Nardi is an anthropologist who studies interactions between humans and computers. In 1993, she published her first book, A Small Matter of Programming. The book’s thesis is bold... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase

Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More

Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs

Xcelerating Life Sciences New York

Adam Wiggins

Recent posts

Three Months in Berlin: One Tech Entrepreneur’s Journey

Programming Literacy Done Right: It’s About the Tools

Underwriters and Partners

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

What’s Next in Neuroscience Therapies

Fish & Richardson: Patent Law in Regards to AI and Machine Learning

Xconomy on Demand

We offer a number of ways to subscribe for free!